Tag Archives: Food and Drug Administration

‘For Shame’: Pfizer to Charge $1,390 for Lifesaving Covid Drug That Costs Just $13

“Pfizer treats Paxlovid like a Prada handbag; a luxury for the few rather than a treatment for the many,” said one consumer advocate.

By Brett Wilkins. Published 10-19-2023 by Common Dreams

Photo: Ministério da Saúde/flickr/CC

U.S. consumer watchdog Public Citizen on Thursday excoriated Pfizer after the pharmaceutical giant announced it would more than double the price of a lifesaving Covid-19 treatment, which will soon sell for an estimated 100 times the cost of production.

Pfizer said Wednesday that it will price its patented Covid treatment nirmatrelvir-ritonavir—sold under the brand name Paxlovid—at $1,390 for a five-day course. Researchers Melissa J. Barber and Dzintars Gotham recently estimated it costs Pfizer $13 to produce five days’ worth of the drug, which is taken in three-pill doses.

Continue reading
Share Button

Appeals Court Upholds Restrictions on Mifepristone—But Abortion Pill Remains Available for Now

“Today’s decision is a likely first step toward a massive blow to reproductive rights in the United States—and a stark reminder that our courts have been hijacked by Republican extremists,” said one abortion rights advocate.

By Brett Wilkins. Published 8-16-2023 by Common Dreams

Mifepristone The pill is one of two used in medication abortions. Photo: Robin Marty/flickr/CC

A federal appellate court on Wednesday upheld portions of a ruling restricting access to the abortion pill mifepristone, although the drug will remain available pending the outcome of ongoing litigation.

A three-judge panel of the right-wing 5th U.S. Circuit Court of Appeals ruled that mifepristone can remain on the market, while finding that the Food and Drug Administration’s (FDA) 2016 move to allow the pill to be taken later in pregnancy, mailed directly to patients, and prescribed by healthcare professionals other than doctors was likely illegal.

Continue reading
Share Button

In ‘Transformative Victory’ for Reproductive Justice, FDA Approves Over-the-Counter Birth Control

If the pill is made affordable and covered by insurance, said one advocate, the approval has the potential to be “a game-changer for communities impacted by systemic health inequities.”

By Julia Conley. Published 7-13-2023 by Common Dreams

The Food and Drug Administration approved the United States’ first over-the-counter birth control pill on July 13, 2023. (Photo: UC Irvine/flickr/cc)

“Groundbreaking,” “monumental,” and “transformative” were just a few of the words rights advocates used on Thursday to describe the U.S. Food and Drug Administration’s long-awaited approval of over-the-counter use of Opill, a birth control pill that was approved for prescription use five decades ago.

The approval could revolutionize access to contraception for young people, low-income people, and others in a country where nearly half of all pregnancies are unintended, said Free the Pill, a coalition of more than 200 reproductive justice groups and advocates who have been campaigning for over-the-counter (OTC) access to birth control for nearly two decades.

Continue reading
Share Button

Abortion Rights Supporters Protest at US Supreme Court, Nationwide

From Florida and Texas to California and Illinois, demonstrators marched with chants like, “Red state, blue state, you can’t hide, the war on abortion is nationwide,” and “Fascist judges make me ill, hands off the abortion pill.”

By Jessica Corbett Published 4-16-2023 by Common Dreams

Lobby Day protest in Texas. Photo: Karthik Soora/Twitter

As legal fights raise concerns about the future accessibility of the abortion medication mifepristone, reproductive rights supporters on Saturday rallied outside the U.S. Supreme Court and in cities across the country.

The demonstrations came a day after the U.S. Supreme Court temporarily blocked a recent ruling by Texas-based federal Judge Matthew Kacsmaryk, an appointee of former President Donald Trump who struck down the U.S. Food and Drug Administration’s 2000 approval of mifepristone, one of two drugs often taken in tandem for abortions.

Continue reading
Share Button

Patients Push Biden HHS to Act as Pharma Firm Charges $190K for Lifesaving Prostate Cancer Drug

“HHS can clearly insist on limiting the U.S. price of Xtandi to the median price for other large high-income countries,” said advocates, “particularly since the drug has already generated more than $10 billion in sales from Medicare alone based upon these unconscionable pricing disparities.”

By Brett Wilkins  Published 11-20-2022 by Common Dreams

Screenshot: GlobalGiving

“Cancer does not wait, nor should cancer patients have to wait for years for their government to act.”

That’s the message patient advocates reiterated in a Friday letter asking the Biden administration to help them secure a lifesaving prostate cancer drug that costs nearly $190,000 per year despite its development being 100% taxpayer-funded.

Last year, prostate cancer patient Eric Sawyer petitioned U.S. Health and Human Services (HHS) Secretary Xavier Becerra to grant march-in rights—under which the government can grant patent licenses to companies other than a drug’s manufacturer—for enzalutamide, which is sold under the brand name Xtandi. Continue reading

Share Button

Nebraska Mother, Daughter Face Abortion Charges After Facebook Shares Chats With Police

“Until Meta gives up surveilling private messages and begins protecting its users with end-to-end encryption, it remains complicit in the surveillance and criminalization of pregnant people,” said one advocate.

By Julia Conley  Published 8-10-2022 by Common Dreams

Photo: iphonedigital/flickr/CC

Digital rights advocates on Tuesday said an abortion case in Nebraska illustrates how powerful tech companies like Facebook could play a major role in prosecutions of people who self-manage abortions as more states ban the procedure, and called on the social media platform to reform its privacy policies to protect users.

The case in Nebraska centers on a 17-year-old girl and her mother, Celeste and Jessica Burgess, who sent messages on Facebook regarding plans to terminate Celeste’s pregnancy prior to Roe v. Wade being overturned in June. Continue reading

Share Button

‘Payoff for 40 Years of Dark Money’: Supreme Court Delivers for Corporate America

“It was the conservative court’s larger agenda to gut the regulatory state and decimate executive powers to protect Americans’ health and safety,” warned one expert.

By Jake Johnson  Published 7-1-2022 by Common Dreams

The interior of the United States Supreme Court. Photo: Phil Roeder/CC

Over the past several decades, corporate lawyers, right-wing activists, Republican officials, and dark money groups with deep pockets have been laying the groundwork for a far-reaching legal assault on the federal government’s ability to regulate U.S. industry—including the oil and gas sector threatening the planet.

On Thursday, their investments bore major fruit.

In a 6-3 decision along ideological lines, a Supreme Court packed with right-wing judges handpicked and boosted by some of the same forces leading the yearslong crusade against the power of regulatory agencies—which conservatives often dub the “administrative state”—dramatically restricted the Environmental Protection Agency’s authority to rein in greenhouse gas pollution from power plants. Continue reading

Share Button

Facebook Removing Posts About Mailing Abortion Pills—But Not Guns

“Corporations are not your allies in the advancement of civil rights,” said one observer.

By Kenny Stancil  Published 6-28-2022 by Common Dreams

Photo: Trusted Reviews/CC

Since the U.S. Supreme Court’s reactionary majority struck down Roe v. Wade last Friday, Facebook and Instagram have been swiftly removing posts informing people that they can obtain federally approved abortion pills through the mail while ignoring posts offering to mail guns.

An Associated Press reporter’s Facebook post that said, “If you send me your address, I will mail you abortion pills,” was removed within one minute on Monday, according to the news outlet. Continue reading

Share Button

Rights Groups Accuse Tech Giants of Throttling Content on Abortion Pills

“More Americans are going to need accurate information on abortion,” said one communications director. “But these platforms have algorithms that surface the opposition and misinformation and misleading content.”

By Jessica Corbett. Published 12-27-2021 by Common Dreams

As anti-choice lawmakers ramp up attacks on reproductive freedom across the United States, new reporting on Monday raised alarm about Big Tech companies limiting access to scientifically accurate content from abortion rights organizations while allowing the spread of misinformation.

Representatives from multiple pro-choice groups told The Hill‘s Rebecca Klar about their struggles trying to circulate credible information on accessing medication abortion—which typically involves two medicines, mifepristone and misoprostol—through platforms including Facebook and Google-owned YouTube. Continue reading

Share Button

‘What a Failed State Looks Like’: GOP Under Fire for Blocking Necessary Funds as Covid Vaccine Distribution Begins

“The end of a tragic, crippling pandemic is in sight and Senate Republicans can’t get around to authorizing any money to complete the job.”

By Jake Johnson, staff writer for Common Dreams. Published 12-14-2020

Margaret Klessens, a 96-year-old World War II veteran, gets the COVID vaccine in Massachusetts. Photo: Dr. Sanjay Gupta/Twitter

As U.S. distribution of the newly approved Pfizer-BioNTech coronavirus vaccine kicked off Sunday with the shipment of millions of doses to sites across the nation, Senate Republicans faced mounting outrage for continuing to block federal funds that crisis-ravaged states and localities desperately need to carry out an unparalleled mass inoculation effort.

Facing large budget shortfalls due to the Covid-19 pandemic and lack of relief from the deadlocked Congress, state and local governments will soon be tasked with executing a rapid vaccination campaign that will require large quantities of supplies as well as new clinics, additional workers, and public outreach—all of which will cost money that states and localities fear they don’t have. Continue reading

Share Button